180 related articles for article (PubMed ID: 23198568)
1. [Molecular targeting agents for advanced or recurrent gastric cancer patients].
Fuse N
Nihon Rinsho; 2012 Oct; 70(10):1819-26. PubMed ID: 23198568
[TBL] [Abstract][Full Text] [Related]
2. Trastuzumab in gastric cancer.
Okines AF; Cunningham D
Eur J Cancer; 2010 Jul; 46(11):1949-59. PubMed ID: 20542421
[TBL] [Abstract][Full Text] [Related]
3. Human epidermal growth factor receptor 2 (HER2) in gastric cancer: a new therapeutic target.
De Vita F; Giuliani F; Silvestris N; Catalano G; Ciardiello F; Orditura M
Cancer Treat Rev; 2010 Nov; 36 Suppl 3():S11-5. PubMed ID: 21129604
[TBL] [Abstract][Full Text] [Related]
4. Targeted therapy for gastric cancer--current status.
Kulig J; Kołodziejczyk P; Kulig P; Legutko J
J Oncol Pharm Pract; 2013 Mar; 19(1):75-81. PubMed ID: 22711713
[TBL] [Abstract][Full Text] [Related]
5. Advanced HER2-positive gastric cancer: current and future targeted therapies.
Pazo Cid RA; Antón A
Crit Rev Oncol Hematol; 2013 Mar; 85(3):350-62. PubMed ID: 23021388
[TBL] [Abstract][Full Text] [Related]
6. Current questions for the treatment of advanced gastric cancer.
Cervantes A; Roda D; Tarazona N; Roselló S; Pérez-Fidalgo JA
Cancer Treat Rev; 2013 Feb; 39(1):60-7. PubMed ID: 23102520
[TBL] [Abstract][Full Text] [Related]
7. Advances in the management of HER2-positive advanced gastric and gastroesophageal junction cancer.
Bang YJ
J Clin Gastroenterol; 2012 Sep; 46(8):637-48. PubMed ID: 22751336
[TBL] [Abstract][Full Text] [Related]
8. Trastuzumab for gastric cancer.
Meza-Junco J; Au HJ; Sawyer MB
Expert Opin Biol Ther; 2009 Dec; 9(12):1543-51. PubMed ID: 19916733
[TBL] [Abstract][Full Text] [Related]
9. [Recent advance of chemotherapy in gastric cancer].
Terazawa T; Shimada Y
Nihon Rinsho; 2012 Oct; 70(10):1783-9. PubMed ID: 23198562
[TBL] [Abstract][Full Text] [Related]
10. How will human epidermal growth factor receptor 2-neu data impact clinical management of gastric cancer?
Lorenzen S; Lordick F
Curr Opin Oncol; 2011 Jul; 23(4):396-402. PubMed ID: 21505336
[TBL] [Abstract][Full Text] [Related]
11. Costs of trastuzumab in combination with chemotherapy for HER2-positive advanced gastric or gastroesophageal junction cancer: an economic evaluation in the Chinese context.
Wu B; Ye M; Chen H; Shen JF
Clin Ther; 2012 Feb; 34(2):468-79. PubMed ID: 22325735
[TBL] [Abstract][Full Text] [Related]
12. Targeted therapy in gastric cancer.
Thiel A; Ristimäki A
APMIS; 2015 May; 123(5):365-72. PubMed ID: 25706252
[TBL] [Abstract][Full Text] [Related]
13. Perspectives for personalization in chemotherapy of advanced gastric cancer.
Boku N
Discov Med; 2010 Feb; 9(45):84-9. PubMed ID: 20193632
[TBL] [Abstract][Full Text] [Related]
14. Treatment options in patients with metastatic gastric cancer: current status and future perspectives.
Bilici A
World J Gastroenterol; 2014 Apr; 20(14):3905-15. PubMed ID: 24744580
[TBL] [Abstract][Full Text] [Related]
15. [Two cases of unresectable advanced gastric cancer treated with S-1, CDDP and trastuzumab].
Ogino T; Kawamura M; Tsutsumi K; Sakamoto N; Kodama H; Machida T; Takahashi T; Takanashi S; Nakamura Y; Ishii R
Gan To Kagaku Ryoho; 2013 Feb; 40(2):237-40. PubMed ID: 23411963
[TBL] [Abstract][Full Text] [Related]
16. Management of advanced gastric cancer.
Price TJ; Shapiro JD; Segelov E; Karapetis CS; Pavlakis N; Van Cutsem E; Shah MA; Kang YK; Tebbutt NC
Expert Rev Gastroenterol Hepatol; 2012 Apr; 6(2):199-208; quiz 209. PubMed ID: 22375525
[TBL] [Abstract][Full Text] [Related]
17. Evolving strategies for overcoming resistance to HER2-directed therapy: targeting the PI3K/Akt/mTOR pathway.
Nahta R; O'Regan RM
Clin Breast Cancer; 2010 Nov; 10 Suppl 3():S72-8. PubMed ID: 21115425
[TBL] [Abstract][Full Text] [Related]
18. Co-expression of erythropoietin receptor with human epidermal growth factor 2 may counteract trastuzumab inhibition in gastric cancer.
Li R; Yuan L; Wang J; Wang J
Med Hypotheses; 2011 Dec; 77(6):948-52. PubMed ID: 21944379
[TBL] [Abstract][Full Text] [Related]
19. [A case of unresectable HER2-positive advanced gastric cancer successfully treated by combination therapy with trastuzumab and paclitaxel].
Ojima E; Nishimura G; Nishijima K; Futagami F; Nakamura T; Hosokawa A
Gan To Kagaku Ryoho; 2012 Nov; 39(12):2339-41. PubMed ID: 23268070
[TBL] [Abstract][Full Text] [Related]
20. Molecularly targeted therapies in advanced gastric cancer.
Janjigian YY; Shah MA
Minerva Gastroenterol Dietol; 2011 Mar; 57(1):75-88. PubMed ID: 21372772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
